REGENXBIO Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	15.23	34.47	57.53	34.52	96.95	345.21
Short-Term Investments	135.26	195.6	177.16	240.74	267.69	112.23
Cash & Short-Term Investments	150.49	230.07	234.69	275.26	364.64	457.44
Cash Growth	-43.82%	-1.97%	-14.74%	-24.51%	-20.29%	-3.85%
Accounts Receivable	10.04	26.38	20.47	24.79	28.08	32.44
Other Receivables	0.42	2.31	0.47	0.7	1.5	2.26
Total Trade Receivables	10.46	28.69	20.95	25.49	29.59	34.7
Other Current Assets	25.99	24.83	22.84	34.92	23.25	28.95
Total Current Assets	186.52	281.28	278	334.97	415.98	518.83
Net Property, Plant & Equipment	147.42	152.01	171.31	192.59	206.8	192.45
Long-Term Investments	-	10.79	10.18	38.87	200.56	391.91
Other Long-Term Assets	7.54	6.64	6.03	6.84	8.43	8.46
Total Assets	341.89	453.03	465.99	573.97	833.27	1,114
Accounts Payable	21.21	21.36	22.8	22.79	27.21	11.39
Accrued Expenses	21.89	38.39	38.07	49.7	46.79	76.11
Current Portion of Long-Term Debt	14.23	39.61	34.31	50.57	48.6	37.89
Current Portion of Leases	7.87	8.29	7.9	7.07	6	1.75
Unearned Revenue	5.92	10.45	0.12	0.15	1.83	3.33
Total Current Liabilities	71.11	118.1	103.19	130.27	130.43	130.47
Long-Term Debt	163.11	147.41	25.38	43.49	89.01	133.46
Long-Term Leases	63.2	65.22	74.13	82.22	88.8	84.93
Other Long-Term Liabilities	23.4	19.58	3.64	6.25	8.83	0.75
Total Long-Term Liabilities	249.7	232.2	103.14	131.96	186.64	219.13
Total Liabilities	320.81	350.3	206.34	262.23	317.07	349.61
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-in Capital	1,238	1,229	1,193	1,021	973.15	928.1
Accumulated Other Comprehensive Income	-0.87	-0.69	-0.74	-4.43	-15.4	-2.57
Retained Earnings	-1,216	-1,126	-932.15	-705.05	-441.55	-161.23
Shareholders' Equity	21.08	102.73	259.65	311.74	516.2	764.3
Total Liabilities & Equity	341.89	453.03	465.99	573.97	833.27	1,114
Total Debt	248.4	260.52	141.72	183.34	232.41	258.03
Net Cash (Debt)	-97.91	-30.45	92.97	91.92	132.24	199.41
Net Cash Growth	-	-	1.14%	-30.49%	-33.69%	-4.95%
Net Cash Per Share	-1.89	-0.59	1.88	2.10	3.06	4.54
Book Value	21.08	102.73	259.65	311.74	516.2	764.3
Book Value Per Share	0.41	1.99	5.24	7.13	11.96	17.40
Tangible Book Value	21.08	102.73	259.65	311.74	516.2	764.3
Tangible Book Value Per Share	0.41	1.99	5.24	7.13	11.96	17.40

Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q